CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 90 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,113,000 | +165.6% | 218,143 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $419,000 | -74.6% | 218,143 | -50.0% | 0.00% | 0.0% |
| Q3 2018 | $1,650,000 | +171.4% | 436,286 | +123.9% | 0.00% | 0.0% |
| Q2 2018 | $608,000 | +54.3% | 194,822 | +18.0% | 0.00% | 0.0% |
| Q1 2018 | $394,000 | -20.4% | 165,060 | +30.3% | 0.00% | 0.0% |
| Q4 2017 | $495,000 | +55.2% | 126,696 | 0.0% | 0.00% | – |
| Q3 2017 | $319,000 | -8.9% | 126,696 | 0.0% | 0.00% | – |
| Q2 2017 | $350,000 | +171.3% | 126,696 | +14.6% | 0.00% | – |
| Q1 2016 | $129,000 | -52.4% | 110,543 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $271,000 | -18.4% | 110,543 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $332,000 | -27.4% | 110,543 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $457,000 | – | 110,543 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |